ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1694

The Lupus Severity Index Accurately Identifies Patients with Severe SLE in a Multi-Ethnic Cohort

Christine A. Peschken1, Carol Hitchon2, David Robinson3, Ada Man3, Annaliese Tisseverasinghe3 and Hani El-Gabalawy2, 1RR 149G, University of Manitoba, Winnipeg, MB, Canada, 2University of Manitoba, Winnipeg, MB, Canada, 3Rheumatology, University of Manitoba, Winnipeg, MB, Canada

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Ethnic studies, severity and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Systemic Lupus Erythematosus – Clinical Poster II: Biomarkers and Outcomes

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

The Lupus Severity Index (LSI)* was recently proposed to stratify patients by disease severity for clinical research. The LSI ranges from 0-10, is calculated using ACR classification criteria (ACRc) and demonstrated high predictive accuracy for severity anchored to major immunosuppressive drug use. We investigated the performance and characteristics of the LSI in a large multiethnic lupus cohort.

 

Methods:

Patients from a single academic center were followed from 1990-2016 using a custom database. Records of all SLE patients were abstracted. Variables included birthdate, diagnosis date, self-reported ethnicity, ACRc, SLICC Damage Index (SDI), treatment and date of death. Ethnicity was categorized into White (WHI), Asian (ASN), Indigenous (IND), and Other. The LSI was calculated from ACRc, and compared between ethnic groups and demographic variables known to be associated with severe SLE using t-tests, ANOVA, Pearson correlation coefficient and logistic regression.

 

Results:

Eight hundred thirty-two SLE patients were identified: 497 (60%) WHI; 220 (26%) IND; 91 (11%) ASN; 24(3%) Other. Mean age was 49±16 years, mean disease duration 15±11 years, 90% female, mean age at diagnosis 35±15; 163 (20%) of patients had died. The mean LSI was 6.9±1.7, range 3.2-9.7. The distribution of the LSI was similar to that in the original dataset (Fig 1A) and the area under the ROC curve, measured against prescription of major immunosuppressive drugs, was 0.69 (95%CI 0.65-0.73). LSI was higher in males compared to females (7.3±1.6 vs. 6.9±1.7; p-0.019), and was negatively associated with onset age (Onset<18yrs LSI=7.8±1.3; 18-50yrs LSI= 6.8±1.7; >50yrs LSI= 6.6±1.6; p<0.001)> LSI correlated with SDI(Pearson 0.28, p<0.001), and was a predictor of accruing any damage (SDI>1) (OR1.2 95% CI 1.1-1.3).LSI was higher in non-whites compared to whites: WHI LSI=6.6±1.7; IND LSI=7.2±1.6;Other LSI=7.3±1.3; ASN LSI 8.1±1.1; p<0.001).  LSI was a predictor of early mortality (Death at age<50, or disease duration<10 years): OR 1.2; 95%CI 1.0-1.3).  The distribution of the LSI varied by ethnic group with more uniformly severe disease in ASN patients (Figure 1B,C) compared to WHI and IND.

 

Conclusion:

Similar to the original publication, a higher LSI correlated with male sex, younger onset age, and non-white ethnicity; all groups shown to have more severe SLE. LSI was also a predictor of damage and early mortality. In addition we also found the distribution of LSI to differ between ethnicities. These findings confirm the utility of the LSI in stratifying patients by severity, and supports further exploration of the LSI to investigate contributors to severe SLE.

*Bello GA et al. Lupus Science & Medicine 2016

 

 


Disclosure: C. A. Peschken, None; C. Hitchon, None; D. Robinson, None; A. Man, None; A. Tisseverasinghe, None; H. El-Gabalawy, None.

To cite this abstract in AMA style:

Peschken CA, Hitchon C, Robinson D, Man A, Tisseverasinghe A, El-Gabalawy H. The Lupus Severity Index Accurately Identifies Patients with Severe SLE in a Multi-Ethnic Cohort [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/the-lupus-severity-index-accurately-identifies-patients-with-severe-sle-in-a-multi-ethnic-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-lupus-severity-index-accurately-identifies-patients-with-severe-sle-in-a-multi-ethnic-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology